This message contains images. If you don't see images, click here to view.
Advertise in this news brief.




Text Version   RSS   Subscribe   Unsubscribe   Archive   Media Kit September 16, 2014

Home   About ADAA   Resources for Professionals   Membership   ADAA Conference   Contact Us         

 




ADAA NEWS

Master Clinicians at conference announced
ADAA
One of the highlights of the upcoming Anxiety and Depression Conference in Miami, Florida, are the Master Clinician sessions. The 2015 conference will feature 12 master clinicians focusing on children and adults with anxiety disorders, depression, OCD, PTSD, insomnia and personality disorders. Sessions will cover pharmacotherapy and psychotherapies including ACT, CBT, DBT and compassion-based therapy. These sessions will be held on Thursday, April 9, 2015. Each session is two hours and all are included in the registration fee. Continuing education credits are available for these sessions.
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE  


ADAA Career Development Travel Awards open
ADAA
The ADAA Career Development Travel Awards are given to help early career professionals who have a research interest in anxiety disorders and depression attend and present a poster at the annual conference. The awards also familiarize and engage aspiring professionals with the membership and work of the association. All award winners are assigned a mentor at the conference. In addition, consideration is given to all winners to present the poster presentation at the annual meeting of either ACNP or ABCT. The deadline for travel awards is Nov. 7.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


RESEARCH AND PRACTICE NEWS


Anxiety medications may be tied to Alzheimer's risk
HealthDay News
Older adults who habitually use sedatives for anxiety or insomnia may have a heightened risk of developing Alzheimer's disease, a new study suggests. The drugs in question are benzodiazepines, a widely prescribed group of sedatives that include lorazepam, diazepam and alprazolam. Older adults commonly take the drugs for anxiety or insomnia, often long-term, according to background information in the study.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Drugs for depression linked with failure of dental implants
Medical News Today
A team from McGill University has discovered that people who take the most common antidepressants are twice as likely to have dental implants fail as those who are not taking selective serotonin reuptake inhibitors. "Because antidepressants, which are widely used around the world, are reported to increase the risk of bone fracture and reduce bone formation, we were curious to see how they might affect dental implants," says Prof. Faleh Tamimi, the lead author on the study and a professor in McGill's School of Dentistry.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Brain imaging could assist bipolar depression diagnosis
News-Medical
Researchers have identified structural brain differences that could help to distinguish patients with unipolar and bipolar depression. Differences in grey and white matter volumes in the amygdala, hippocampus and anterior cingulate gyrus distinguished the two groups from each other with nearly 70 percent accuracy, report Udo Dannlowski and team.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Why does the placebo response work in treating depression?
Medical Xpress
In the past three decades, the power of placebos has gone through the roof in treating major depressive disorder. In clinical trials for treating depression over that period of time, researchers have reported significant increases in patient's response rates to placebos — the simple sugar pills given to patients who think that it may be actual medication.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Collaborative care intervention improves depression among teens
JAMA via Science Daily
Among adolescents with depression seen in primary care, a collaborative care intervention that included patient and parent engagement and education resulted in greater improvement in depressive symptoms at 12 months than usual care, according to a study in the Aug. 27 issue of JAMA. Depressed youth are at greater risk of suicide, substance abuse, early pregnancy, low educational attainment, recurrent depression and poor long-term health.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Weight loss linked to depression finds new study
eCanadaNow
Weight loss ads usually show happy people, ecstatic that they are finally living a healthy life. Recent research suggests that psychologically, these people might not be as healthy as others think. According to a British research spanning over 4 years, approximately 2000 obese and overweight adults showed increased rates of depression as their body weight was lost by more than 5 percent.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Urticaria in adolescence increases the risk of developing new-onset depression
MDLinx
In this study, the authors aim was to analyze the risk of depression following a diagnosis of urticaria using a nationwide population–based study. Individuals who experience an initial attack of urticaria during adolescence are at a higher risk for developing depression.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


What are the neural circuits activated by cognitive behavioral therapy?
Medical News Today
A new study published in the current issue of Psychotherapy and Psychosomatics provides new insights on how psychotherapy works. Cognitive behavioral therapy (CBT) is an effective treatment for panic disorder with agoraphobia (PD/AG). It is unknown, how variants of CBT differentially modulate brain networks involved in PD/AG. This study evaluated the effects of therapist-guided versus self-guided exposure on the neural correlates of fear conditioning in PD/AG.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Pain and depression treatment possible in fibromyalgia
Medscape (free subscription)
Patients with fibromyalgia can safely be treated with the anticonvulsant drug pregabalin for their pain while at the same time being treated for depression, a new study shows. Results of a double-blind study showed that pregabalin significantly improved mean pain scores compared with placebo in patients with fibromyalgia taking a selective serotonin reuptake inhibitor or a serotonin/norepinephrine reuptake inhibitor.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Researchers use computer-based treatment for children with anxiety
Medical Xpress
When traditional methods of treatment do not work for children suffering from anxiety disorders, researchers at Florida International University believe they have found another option. Ph.D. student Michele Bechor and Psychology Professor Jeremy Pettit decided to try attention bias modification treatment for these children, a computer-based method that seems more like a video game to kids than therapy.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Low serotonin levels don't cause depression
PsychCentral
One of the leading myths that unfortunately still circulates about clinical depression is that it’s caused by low serotonin levels in the brain. This is a myth because countless scientific studies have specifically examined this theory and have come back universally rejecting it. So let’s put it to rest once and for all — low levels of serotonin in the brain don’t cause depression.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Reduced amygdala and ventral striatal activity to happy faces in PTSD is associated with emotional numbing
PLOS ONE
There has been a growing recognition of the importance of reward processing in PTSD, yet little is known of the underlying neural networks. This study tested the predictions that individuals with PTSD would display reduced responses to happy facial expressions in ventral striatal reward networks and that this reduction would be associated with emotional numbing symptoms.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


New developments in the genetics of bipolar disorder
Current Psychiatry Reports
The last several years have been breakthrough ones in bipolar disorder genetics, as the field has identified robust risk variants for the first time. Leading the way have been genome-wide association studies that have assessed common genetic markers across very large groups of patients and controls.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Blood test for depression developed after scientists discover condition causes a spike in certain chemicals
The Daily Mail via Pakistan Today
A blood test for depression has been developed by scientists. They hope it will drastically speed up the diagnosis time for the condition and lead to quicker treatment. At present, clinical depression can take several months to diagnose as doctors try to decide whether the patient has the condition or whether they are simply experiencing natural feelings of sadness caused by an event or tragedy.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE
About Anxiety & Depression Insights

This news brief is a timely update about anxiety disorders and depression sent to members of the Anxiety and Depression Association of America and other professionals interested in this area. Links to articles are provided for the convenience of the reader. External resources are not a part of the ADAA website, and ADAA is not responsible for the content of external sites. Linking to a website does not constitute an endorsement by ADAA of the sponsors of the site or the information presented on the site. For more information about ADAA, visit www.ADAA.org.
 



Anxiety & Depression Insights
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Lauren Swan, Content Editor, 202.684.7496  
Contribute news


Be sure to add us to your address book or safe sender list so our emails get to your inbox. Learn how.

This edition of Anxiety & Depression Insights was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here -- it's free!

Recent issues

Sept. 2, 2014
Aug. 19, 2014







7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063